chevron_leftBack
As of 24 April 2025, Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. has a market cap of $478.63M USD, ranking #12165 globally and #3898 in China. It ranks #1190 in the Healthcare sector, and #54 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$478.63MUSD
3.49B CNY
Enterprise Value
$497.98MUSD
3.63B CNY
Revenue (TTM)
$98.11MUSD
714.95M CNY
EBITDA (TTM)
$13.93MUSD
101.52M CNY
Net Income (TTM)
-$17.67MUSD
-128.76M CNY
EBITDA Margin
14%
Profit Margin
-18%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jinfang Lou
open_in_new
Employees
1,747
Founded
2011
Website
hzbio-s.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.3% | -2.7% | -14% | -5.4% | -27% | -57% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
301096
杭州百诚医药科技股份有限公司 Class A
ISIN: CNE1000056N5
Shares Out.:
Shares Outstanding:
108.451M1
Shares Float:
83.935M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
32.06 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies. Its business covers the principal links of drug discovery, pharmaceutical research, clinical trials, customized research and development and production, and registration applications. The company was founded in 2011 and is headquartered in Hangzhou, China.
